FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, particularly to ophthalmology, and is intended for the preparation of an ophthalmic composition for soft contact lenses. Ophthalmic composition for soft contact lenses comprises pranoprofen and/or a pharmaceutically acceptable salt thereof and cations other than hydrogen ions, in an equivalent of 140 mEq/l or less. Said composition has a pH in the range of 5.5 to 8. Also disclosed are methods for suppressing the adsorption of pranoprofen and/or a pharmaceutically acceptable salt thereof on soft contact lenses.
EFFECT: use of the group of inventions makes it possible to suppress the adsorption of pranoprofen and/or salt thereof on soft contact lenses in order to avoid a side effect on soft contact lenses, providing an effective therapeutic effect of pranoprofen and/or salt thereof.
12 cl, 8 tbl, 7 ex
Authors
Dates
2018-06-28—Published
2014-03-06—Filed